USPTO serial 87777993
ARMIS BIOPHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 1, 2021
- Examiner
- KENEALY, NATALIE LANGFORD
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ARMIS BIOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Fort Collins, CO, US
Fort Collins, CO, US
FT. COLLINS, CO, US
Fort Collins, CO, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jonathan R. Lagarenne
Jonathan R. Lagarenne Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical ingredients in the nature of antimicrobial substances and preparations for medical purposes for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; chemical ingredients in the nature of antimicrobial substances sold as a component ingredient of irrigation solutions, namely, medical cleansers for wounds; biostatic antimicrobial preparations for treating, inhibiting and preventing viruses, fungus, mold, bacteria, spores and biofilms; wound antiseptic, medicated cleansers for skin and wounds, and wound irrigation agents, namely, medicated wash and sterilizing preparations; medical cleansers for skin; cleansing solutions for medical use; all purpose disinfecting preparations; topical gel for medical and therapeutic treatment of wounds and other skin disorders; antiseptic preparations; antiseptics; Antibacterial and antibiotic preparations for medical use | ACTIVE | Feb 13, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks owned by ARMIS BIOPHARMA, INC.
- Other trademarks owned by Armis Biopharma, Inc.
- Other trademarks in Class 005
- Similar marks named ARMIS BIOPHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 1, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 11, 2025 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 1, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 30, 2021 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 29, 2021 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 31, 2021 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 4, 2021 | IUAF | USE AMENDMENT FILED | — |
| Mar 4, 2021 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 8, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 4, 2020 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 4, 2020 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 4, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 29, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 27, 2020 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 27, 2020 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 27, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 19, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 19, 2019 | NOAC | CORRECTED NOA E-MAILED | — |
| Sep 18, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 18, 2019 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Sep 18, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 4, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 4, 2019 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Sep 4, 2019 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Sep 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 4, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 4, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 4, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 10, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 6, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 21, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 21, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 21, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 21, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 14, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 9, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 3, 2018 | NWAP | NEW APPLICATION ENTERED | — |